Orion Market Research Pvt. Ltd. info@omrglobal.com +91 780-304-0404
Help Center
Careers
Contact

Opioid Use Disorder Treatment Market

Opioid Use Disorder Treatment Market Size, Share & Trends Analysis Report, By Treatment Type (Pharmacotherapy, Behavioural Therapy, Combined Treatment), By Drug Type (Partial Opioid Agonists, Full Opioid Agonists, Opioid Antagonists), By End-User (Hospitals, Specialty Addiction Treatment Centers, Rehabilitation Centers, Ambulatory Care Centers, Homecare Settings), Forecast Period (2026-2035)

Published: May 2026 | Report Code: OMR2029595 | Category : Pharmaceuticals | Delivery Format: /

Industry Overview

Opioid use disorder treatment market size was valued at $4.65 billion in 2025 and is projected to reach $12.82 billion by 2035, growing at a CAGR of 10.66% between 2026 and 2035. The market consists of treatment solutions focused on managing opioid dependence through pharmacological and behavioural interventions. These therapies play a critical role in reducing withdrawal symptoms, preventing relapse, and improving long-term patient outcomes across healthcare settings. A key driver supporting market growth is the rising global burden of opioid addiction. According to the World Health Organization, over 39 million people globally suffer from drug use disorders, with opioids accounting for a significant proportion of drug-related deaths. Additionally, increasing healthcare investments and policy initiatives are strengthening treatment infrastructure. Rising adoption of medication-assisted treatment and expansion of rehabilitation services across hospitals and specialty centers are further driving market growth.

Market Dynamics

Rising Prevalence of Opioid Addiction Driving Market Growth

The increasing prevalence of opioid addiction is a major factor driving the opioid use disorder treatment market. Opioid misuse has become a significant global public health concern, leading to rising demand for effective treatment solutions. According to the World Health Organization, opioids are responsible for a majority of drug-related deaths worldwide. Governments are implementing national strategies and expanding access to treatment programs to address this crisis. Additionally, regulatory support from organizations such as the U.S. Food and Drug Administration has accelerated the approval of advanced treatment options. Pharmaceutical companies are focusing on developing long-acting formulations and combination therapies between 2023 and 2026 to improve patient compliance and treatment effectiveness.

High Treatment Costs Limiting Market Growth

Despite strong growth potential, the market faces challenges due to high treatment costs and limited accessibility in developing regions. Treatment programs often require long-term therapy, increasing the financial burden on patients and healthcare systems. According to the Organisation for Economic Co-operation and Development, disparities in healthcare spending impact the availability of mental health and addiction services globally. Additionally, social stigma associated with addiction discourages individuals from seeking timely treatment. To address these challenges, companies are focusing on cost-effective drug formulations, expanding telehealth solutions, and increasing awareness initiatives to improve access to treatment services.

Market Segmentation

  • Based on the treatment type, the market is segmented into pharmacotherapy, behavioural therapy, and combined treatment.
  • Based on the drug type, the market is segmented into partial opioid agonists, full opioid agonists, and opioid antagonists.
  • Based on the end-user, the market is segmented into hospitals, specialty addiction treatment centers, rehabilitation centers, ambulatory care centers, and homecare settings.

Pharmacotherapy Segment Leads the Market

The pharmacotherapy segment holds a dominant position in the opioid use disorder treatment market due to its high effectiveness in managing withdrawal symptoms and reducing opioid cravings. Medications such as buprenorphine and methadone are widely used across clinical settings. Increasing demand for medication-assisted treatment and regulatory approvals for advanced drug formulations between 2022 and 2026 are driving segment growth. Companies are focusing on improving drug delivery systems and developing long-acting therapies to enhance treatment adherence and outcomes.

Combined Treatment Segment to Record Strong Growth

The combined treatment segment is expected to witness strong growth due to increasing adoption of integrated treatment approaches. These approaches combine pharmacological therapy with behavioural interventions to address both physical and psychological aspects of addiction. Rising awareness of comprehensive treatment methods and increasing investment in rehabilitation programs are supporting segment growth. Additionally, digital health platforms and telemedicine are enhancing patient monitoring and engagement, further strengthening the segment.

Regional Outlook

The global opioid use disorder treatment market is geographically segmented into North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa and Latin America).

United States Leads the Market

The United States dominates the opioid use disorder treatment market due to high prevalence of opioid addiction and strong healthcare infrastructure. Government initiatives and increased funding for addiction treatment programs are supporting market growth. The presence of leading pharmaceutical companies and continuous product innovation further strengthen the market.

China to Record Strong Growth

China is expected to witness strong growth due to increasing healthcare investments and expansion of pharmaceutical manufacturing capabilities. Rising awareness of addiction treatment and improving healthcare infrastructure are driving market growth. Government initiatives to enhance mental healthcare services are further supporting market expansion.

Competitive Landscape
The opioid use disorder treatment market is highly competitive, with companies focusing on innovation, strategic collaborations, and expanding treatment accessibility. Leading players such as Indivior PLC, Alkermes plc, Camurus AB, Orexo AB, and Hikma Pharmaceuticals are investing in research and development to introduce advanced treatment solutions and strengthen their global presence.

Recent Developments

  • In March 2026, Hikma Pharmaceuticals PLC launched an authorized generic version of Nucynta® ER (tapentadol) extended release in the United States, marking the first generic availability of this product. The launch, following its February 2026 immediate-release version, strengthens Hikma’s pain management portfolio, improves patient access to cost-effective opioid therapies, and enhances its competitive positioning in the U.S. market.
  • In January 2026, Camurus AB announced that the U.S. Food and Drug Administration accepted the resubmission of its New Drug Application for Oclaiz™ (CAM2029), an extended-release octreotide injection for acromegaly treatment. The acceptance, along with a PDUFA target action date of June 2026, strengthens the company’s regulatory pipeline and supports expansion of its long-acting therapeutic portfolio with improved patient convenience through monthly self-administration.

The Report Covers

  • Market value data analysis of 2025 and forecast to 2035.
  • Annualised market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global opioid use disorder treatment market. Based on the availability of data, information related to new products and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying ‘who-stands-where’ in the market.

 

  1. Report Summary
  • Current Industry Analysis and Growth Potential Outlook
  • Global Opioid Use Disorder Treatment Market Sales Analysis – Treatment Type | Drug Type | End-User ($ Million)
  • Opioid Use Disorder Treatment Market Sales Performance of Top Countries

1.1 Research Methodology

  • Primary Research Approach
  • Secondary Research Approach

1.2 Market Snapshot

  1. Market Overview and Insights
    2.1 Scope of the Study
    2.2 Analyst Insight & Current Market Trends

2.2.1 Key Opioid Use Disorder Treatment Market Trends
2.2.2 Market Recommendations

2.3 Porter's Five Forces Analysis for the Opioid Use Disorder Treatment Market

2.3.1 Competitive Rivalry
2.3.2 Threat of New Entrants
2.3.3 Bargaining Power of Suppliers
2.3.4 Bargaining Power of Buyers
2.3.5 Threat of Substitutes

  1. Market Determinants
    3.1 Market Drivers

3.1.1 Drivers For Global Opioid Use Disorder Treatment Market: Impact Analysis
3.2 Market Pain Points and Challenges

3.2.1 Restraints For Global Opioid Use Disorder Treatment Market: Impact Analysis
3.3 Market Opportunities

3.3.1 Opportunities For Global Opioid Use Disorder Treatment Market: Impact Analysis

  1. Competitive Landscape
    4.1 Competitive Dashboard – Opioid Use Disorder Treatment Market Revenue and Share by Manufacturers
  • Opioid Use Disorder Treatment Product Comparison Analysis
  • Top Market Player Ranking Matrix

4.2 Key Company Analysis

4.2.1 Indivior PLC

4.2.1.1 Overview
4.2.1.2 Product Portfolio
4.2.1.3 Financial Analysis
4.2.1.4 SWOT Analysis
4.2.1.5 Business Strategy

4.2.2 Alkermes plc

4.2.2.1 Overview
4.2.2.2 Product Portfolio
4.2.2.3 Financial Analysis
4.2.2.4 SWOT Analysis
4.2.2.5 Business Strategy

4.2.3 Camurus AB

4.2.3.1 Overview
4.2.3.2 Product Portfolio
4.2.3.3 Financial Analysis
4.2.3.4 SWOT Analysis
4.2.3.5 Business Strategy

4.2.4 Orexo AB

4.2.4.1 Overview
4.2.4.2 Product Portfolio
4.2.4.3 Financial Analysis
4.2.4.4 SWOT Analysis
4.2.4.5 Business Strategy

4.2.5 Hikma Pharmaceuticals

4.2.5.1 Overview
4.2.5.2 Product Portfolio
4.2.5.3 Financial Analysis
4.2.5.4 SWOT Analysis
4.2.5.5 Business Strategy

4.3 Top Winning Strategies by Market Players

4.3.1 Merger and Acquisition
4.3.2 Product Launch
4.3.3 Partnership And Collaboration

  1. Global Opioid Use Disorder Treatment Market Sales Analysis by Treatment Type ($ Million)

5.1 Pharmacotherapy
5.2 Behavioural Therapy
5.3 Combined Treatment

  1. Global Opioid Use Disorder Treatment Market Sales Analysis by Drug Type ($ Million)

6.1 Partial Opioid Agonists
6.2 Full Opioid Agonists
6.3 Opioid Antagonists

  1. Global Opioid Use Disorder Treatment Market Sales Analysis by End-User ($ Million)

7.1 Hospitals
7.2 Speciality Addiction Treatment Centres
7.3 Rehabilitation Centres
7.4 Ambulatory Care Centres
7.5 Homecare Settings

  1. Regional Analysis
    8.1 North American Opioid Use Disorder Treatment Market Sales Analysis – Treatment Type | Drug Type | End-User ($ Million)

8.1.1 United States
8.1.2 Canada

8.2 European Opioid Use Disorder Treatment Market Sales Analysis – Treatment Type | Drug Type | End-User ($ Million)

8.2.1 UK
8.2.2 Germany
8.2.3 Italy
8.2.4 Spain
8.2.5 France
8.2.6 Russia
8.2.7 Rest of Europe

8.3 Asia-Pacific Opioid Use Disorder Treatment Market Sales Analysis – Treatment Type | Drug Type | End-User ($ Million)

8.3.1 China
8.3.2 Japan
8.3.3 South Korea
8.3.4 India
8.3.5 Australia & New Zealand
8.3.6 ASEAN Countries
8.3.7 Rest of Asia-Pacific

8.4 Rest of the World Opioid Use Disorder Treatment Market Sales Analysis – Treatment Type | Drug Type | End-User ($ Million)

8.4.1 Latin America
8.4.2 Middle East and Africa

  1. Company Profiles
    9.1 Amneal Pharmaceuticals
    9.1.1 Quick Facts
    9.1.2 Company Overview
    9.1.3 Product Portfolio
    9.1.4 Business Strategies

9.2 Apotex Inc.
9.2.1 Quick Facts
9.2.2 Company Overview
9.2.3 Product Portfolio
9.2.4 Business Strategies

9.3 Ascent Pharmaceuticals
9.3.1 Quick Facts
9.3.2 Company Overview
9.3.3 Product Portfolio
9.3.4 Business Strategies

9.4 Aurobindo Pharma
9.4.1 Quick Facts
9.4.2 Company Overview
9.4.3 Product Portfolio
9.4.4 Business Strategies

9.5 BioCorRx Inc.
9.5.1 Quick Facts
9.5.2 Company Overview
9.5.3 Product Portfolio
9.5.4 Business Strategies

9.6 Braeburn
9.6.1 Quick Facts
9.6.2 Company Overview
9.6.3 Product Portfolio
9.6.4 Business Strategies

9.7 Cipla Ltd.
9.7.1 Quick Facts
9.7.2 Company Overview
9.7.3 Product Portfolio
9.7.4 Business Strategies

9.8 Dr Reddy’s Laboratories
9.8.1 Quick Facts
9.8.2 Company Overview
9.8.3 Product Portfolio
9.8.4 Business Strategies

9.9 Glenmark Pharmaceuticals
9.9.1 Quick Facts
9.9.2 Company Overview
9.9.3 Product Portfolio
9.9.4 Business Strategies

9.10 Lannett Company
9.10.1 Quick Facts
9.10.2 Company Overview
9.10.3 Product Portfolio
9.10.4 Business Strategies

9.11 Lupin Pharmaceuticals
9.11.1 Quick Facts
9.11.2 Company Overview
9.11.3 Product Portfolio
9.11.4 Business Strategies

9.12 Mallinckrodt Pharmaceuticals
9.12.1 Quick Facts
9.12.2 Company Overview
9.12.3 Product Portfolio
9.12.4 Business Strategies

9.13 Mayne Pharma Group
9.13.1 Quick Facts
9.13.2 Company Overview
9.13.3 Product Portfolio
9.13.4 Business Strategies

9.14 Rhodes Pharmaceuticals
9.14.1 Quick Facts
9.14.2 Company Overview
9.14.4 Business Strategies

9.15 Sandoz
9.15.1 Quick Facts
9.15.2 Company Overview
9.15.3 Product Portfolio
9.15.4 Business Strategies

9.16 Sun Pharmaceutical Industries
9.16.1 Quick Facts
9.16.2 Company Overview
9.16.3 Product Portfolio
9.16.4 Business Strategies

9.17 Teva Pharmaceutical Industries
9.17.1 Quick Facts
9.17.2 Company Overview
9.17.3 Product Portfolio
9.17.4 Business Strategies

9.18 Titan Pharmaceuticals
9.18.1 Quick Facts
9.18.2 Company Overview
9.18.3 Product Portfolio
9.18.4 Business Strategies

9.19 Viatris Inc.
9.19.1 Quick Facts
9.19.2 Company Overview
9.19.3 Product Portfolio
9.19.4 Business Strategies

9.20 Zydus Pharmaceuticals
9.20.1 Quick Facts
9.20.2 Company Overview
9.20.3 Product Portfolio
9.20.4 Business Strategies

1. Global Opioid Use Disorder Treatment Market Research and Analysis by Treatment Type, 2025–2035 ($ Million) 

2. Global Pharmacotherapy Opioid Use Disorder Treatment Market Research and Analysis by Region, 2025–2035 ($ Million) 

3. Global Behavioural Therapy Opioid Use Disorder Treatment Market Research and Analysis by Region, 2025–2035 ($ Million) 

4. Global Combined Treatment Opioid Use Disorder Treatment Market Research and Analysis by Region, 2025–2035 ($ Million) 

5. Global Opioid Use Disorder Treatment Market Research and Analysis by Drug Type, 2025–2035 ($ Million) 

6. Global Partial Opioid Agonists Opioid Use Disorder Treatment Market Research and Analysis by Region, 2025–2035 ($ Million) 

7. Global Full Opioid Agonists Opioid Use Disorder Treatment Market Research and Analysis by Region, 2025–2035 ($ Million) 

8. Global Opioid Antagonists Opioid Use Disorder Treatment Market Research and Analysis by Region, 2025–2035 ($ Million) 

9. Global Opioid Use Disorder Treatment Market Research and Analysis by End-User, 2025–2035 ($ Million) 

10. Global Opioid Use Disorder Treatment for Hospitals Market Research and Analysis by Region, 2025–2035 ($ Million) 

11. Global Opioid Use Disorder Treatment for Speciality Addiction Treatment Centres Market Research and Analysis by Region, 2025–2035 ($ Million) 

12. Global Opioid Use Disorder Treatment for Rehabilitation Centres Market Research and Analysis by Region, 2025–2035 ($ Million) 

13. Global Opioid Use Disorder Treatment for Ambulatory Care Centres Market Research and Analysis by Region, 2025–2035 ($ Million) 

14. Global Opioid Use Disorder Treatment for Homecare Settings Market Research and Analysis by Region, 2025–2035 ($ Million) 

15. Global Opioid Use Disorder Treatment Market Research and Analysis by Region, 2025–2035 ($ Million) 

16. North America Opioid Use Disorder Treatment Market Research and Analysis by Country, 2025–2035 ($ Million) 

17. North America Opioid Use Disorder Treatment Market Research and Analysis by Treatment Type, 2025–2035 ($ Million) 

18. North America Opioid Use Disorder Treatment Market Research and Analysis by Drug Type, 2025–2035 ($ Million) 

19. North America Opioid Use Disorder Treatment Market Research and Analysis by End-User, 2025–2035 ($ Million) 

20. Europe Opioid Use Disorder Treatment Market Research and Analysis by Country, 2025–2035 ($ Million) 

21. Europe Opioid Use Disorder Treatment Market Research and Analysis by Treatment Type, 2025–2035 ($ Million) 

22. Europe Opioid Use Disorder Treatment Market Research and Analysis by Drug Type, 2025–2035 ($ Million) 

23. Europe Opioid Use Disorder Treatment Market Research and Analysis by End-User, 2025–2035 ($ Million) 

24. Asia-Pacific Opioid Use Disorder Treatment Market Research and Analysis by Country, 2025–2035 ($ Million) 

25. Asia-Pacific Opioid Use Disorder Treatment Market Research and Analysis by Treatment Type, 2025–2035 ($ Million) 

26. Asia-Pacific Opioid Use Disorder Treatment Market Research and Analysis by Drug Type, 2025–2035 ($ Million) 

27. Asia-Pacific Opioid Use Disorder Treatment Market Research and Analysis by End-User, 2025–2035 ($ Million) 

28. Rest of the World Opioid Use Disorder Treatment Market Research and Analysis by Region, 2025–2035 ($ Million) 

29. Rest of the World Opioid Use Disorder Treatment Market Research and Analysis by Treatment Type, 2025–2035 ($ Million) 

30. Rest of the World Opioid Use Disorder Treatment Market Research and Analysis by Drug Type, 2025–2035 ($ Million) 

31. Rest of the World Opioid Use Disorder Treatment Market Research and Analysis by End-User, 2025–2035 ($ Million) 

1. Global Opioid Use Disorder Treatment Market Share by Treatment Type, 2025 Vs 2035 (%) 

2. Global Pharmacotherapy Opioid Use Disorder Treatment Market Share by Region, 2025 Vs 2035 (%) 

3. Global Behavioural Therapy Opioid Use Disorder Treatment Market Share by Region, 2025 Vs 2035 (%) 

4. Global Combined Treatment Opioid Use Disorder Treatment Market Share by Region, 2025 Vs 2035 (%) 

5. Global Opioid Use Disorder Treatment Market Share by Drug Type, 2025 Vs 2035 (%) 

6. Global Partial Opioid Agonists Opioid Use Disorder Treatment Market Share by Region, 2025 Vs 2035 (%) 

7. Global Full Opioid Agonists Opioid Use Disorder Treatment Market Share by Region, 2025 Vs 2035 (%) 

8. Global Opioid Antagonists Opioid Use Disorder Treatment Market Share by Region, 2025 Vs 2035 (%) 

9. Global Opioid Use Disorder Treatment Market Share by End-User, 2025 Vs 2035 (%) 

10. Global Opioid Use Disorder Treatment for Hospitals Market Share by Region, 2025 Vs 2035 (%) 

11. Global Opioid Use Disorder Treatment for Speciality Addiction Treatment Centres Market Share by Region, 2025 Vs 2035 (%) 

12. Global Opioid Use Disorder Treatment for Rehabilitation Centres Market Share by Region, 2025 Vs 2035 (%) 

13. Global Opioid Use Disorder Treatment for Ambulatory Care Centres Market Share by Region, 2025 Vs 2035 (%) 

14. Global Opioid Use Disorder Treatment for Homecare Settings Market Share by Region, 2025 Vs 2035 (%) 

15. Global Opioid Use Disorder Treatment Market Share by Region, 2025 Vs 2035 (%) 

16. US Opioid Use Disorder Treatment Market Size, 2025–2035 ($ Million) 

17. Canada Opioid Use Disorder Treatment Market Size, 2025–2035 ($ Million) 

18. UK Opioid Use Disorder Treatment Market Size, 2025–2035 ($ Million) 

19. France Opioid Use Disorder Treatment Market Size, 2025–2035 ($ Million) 

20. Germany Opioid Use Disorder Treatment Market Size, 2025–2035 ($ Million) 

21. Italy Opioid Use Disorder Treatment Market Size, 2025–2035 ($ Million) 

22. Spain Opioid Use Disorder Treatment Market Size, 2025–2035 ($ Million) 

23. Russia Opioid Use Disorder Treatment Market Size, 2025–2035 ($ Million) 

24. India Opioid Use Disorder Treatment Market Size, 2025–2035 ($ Million) 

25. China Opioid Use Disorder Treatment Market Size, 2025–2035 ($ Million) 

26. Japan Opioid Use Disorder Treatment Market Size, 2025–2035 ($ Million) 

27. South Korea Opioid Use Disorder Treatment Market Size, 2025–2035 ($ Million) 

28. Australia & New Zealand Opioid Use Disorder Treatment Market Size, 2025–2035 ($ Million) 

29. ASEAN Opioid Use Disorder Treatment Market Size, 2025–2035 ($ Million) 

30. Rest of Asia-Pacific Opioid Use Disorder Treatment Market Size, 2025–2035 ($ Million) 

31. Latin America Opioid Use Disorder Treatment Market Size, 2025–2035 ($ Million) 

32. Middle East & Africa Opioid Use Disorder Treatment Market Size, 2025–2035 ($ Million)

Choose License Type
    On Discount
Enterprise Custom
  • Printable version
  • No restriction to number of users within the company
CONTACT SALES

100%
Secured Payment

Why buy from us?
  • Covers more than 15 major industries, which are further segmented into 90+ sectors
  • 65% of our clients are loyal customers
  • 120+ countries are covered in analysis
  • currently servicing 1000+ customers globally
  • 100+ paid data sources mined to research
  • Our expert team will assist you with all research need and customization
  • Our expert research analyst will resolve your every query before and after purchasing the report
Related Reports

FAQS

The size of the Opioid Use Disorder Treatment Market in 2025 is estimated to be around $4.65 billion.
United States holds the largest share in the Opioid Use Disorder Treatment Market.
Leading players in the Opioid Use Disorder Treatment Market Includes Pfizer Inc., AbbVie Inc., Teva Pharmaceutical Industries Ltd., Ipsen Biopharmaceuticals Inc., and Novartis AG., among others.
The Opioid Use Disorder Treatment Market is expected to grow at a CAGR of 10.66% from 2026 to 2035.
Rising prevalence of opioid addiction, increasing awareness about substance abuse treatment, and growing government initiatives for rehabilitation and mental healthcare are driving the Opioid Use Disorder Treatment Market growth.